NCT00317330View on ClinicalTrials.gov

A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis

PHASE3CompletedINTERVENTIONAL
Enrollment

6,400

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

June 30, 2005

Conditions
Tuberculosis
Interventions
DRUG

Isoniazid

DRUG

Pyrazinamide

DRUG

Rifampin

Trial Locations (1)

21945

Municipal Health Department, Rio de Janeiro

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00317330 - A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis | Biotech Hunter | Biotech Hunter